This article reviews the recent literature on health services use by drug abusers. A revised Andersen-Newman model is posited as a theoretical orientation for health service initiatives focused on drug abuse. The model highlights specific predisposing factors, historical health factors, current illness factors, and enabling/mediating factors associated with drug abuse. The limited number of cost-effectiveness studies have demonstrated that publicly funded drug treatment can produce savings by reducing selected health care costs and decreasing crime. However, short-term costs related to drug abuse can be greater to realize than long-term savings. The criminal justice system can serve as a point of contact and provides a concentrated reservoir of drug users. However, drug-abusing offenders are more likely to present a variety of health problems including hepatitis, tuberculosis, and HIV/AIDS. From a managed care and health services use perspective, drug abuse treatment in the criminal justice system should minimize long-term health care- and crime-related costs.
Get full access to this article
View all access options for this article.
References
1.
Andersen, R. , & Anderson, O. W. (1979). Trends in the use of health services. In H. E. Freeman, S. Levine, & L. G. Reeder (Eds.), Handbook of medical sociology (3rd ed., pp. 371-391). Englewood Cliffs, NJ: Prentice Hall.
2.
Andersen, R. , & Newman, J. F. (1973). Societal and individual determinants of medical care utilization in the United States. Milbank Memorial Fund Quarterly, 51, 95-124.
3.
Anthony, J. C. , Helzer, J. E. (1991). Syndromes of drug abuse and dependence. In L. N. Robins & D. A. Regier (Eds.), Psychiatric disorders in America. New York: Free Press.
4.
Apsler, R. (1991). Evaluating the cost-effectiveness of drug abuse treatment. In W. S. Cartwright & J. M. Kaple (Eds.), Economic costs, cost-effectiveness, financing, and community-based drug treatment (pp. 57-66). Washington, DC: U.S. Government Printing Office.
5.
Apsler, R. , & Harding, W. M. (1991). Cost-effectiveness analysis of drug abuse treatment: Current status and recommendations for future research. In Drug Abuse Services Research Series No. 1: Background papers on drug abuse financing and services approach (National Institute on Drug Abuse). Washington, DC: U.S. Government Printing Office.
6.
Ashery, R. S. , Carlson, R. G., Falck, R. S., & Siegal, H. A. (1995). Injection drug users, crack-cocaine users, and human service utilization: An exploratory study. Social Work, 40, 75-82.
7.
Barthwell, A. G. , & Gibert, C. L. (1993). Screening for infectious diseases among substance abusers (CSAT-TIP No. 6). Rockville, MD: Center for Substance Abuse Treatment.
8.
Becker, M. H. (1974). The health belief model and personal health behavior. Health Education Monographs, 2, 324-473.
9.
Becker, M. H. (1990). Theoretical models of adherence and strategies for improving adherence. In S. A. Shumaker, E. B. Schron, & J. K. Ockene (Eds.), The handbook of health behavior change (pp. 5-43). New York: Springer.
10.
Broadhead, W. E. , Gehlbach, S. H., DeGruy, F. V., & Kaplan, B. H. (1989). Functional versus structural social support and health care utilization in a family medicine outpatient practice. Medical Care, 27, 221-233.
11.
Bury, G. , O'Kelly, F., & Pomeroy, L. (1993). The use of primary care services by drug users attending a HIV prevention unit. Irish Medical Journal, 86(2), 53-55.
12.
California Department of Alcohol and Drug Problems . (1994). Evaluating recovery services: The California Drug and Alcohol Treatment Assessment (CALDATA). Sacramento: California Department of Alcohol and Drug Problems.
13.
Center for Substance Abuse Research . (1992, August 10). Illicit drug use continues unabated in booked arrestees in large cities. CESAR FAX. College Park: University of Maryland.
14.
Cherubin, C. E. , & Sapira, J. D. (1993). The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later. Annals of Internal Medicine, 119(10), 1017-1028.
15.
Chitwood, D. D. , & Morningstar, P. C. (1985). Factors which differentiate cocaine users in treatment from nontreatment. The International Journal of the Addictions, 20(3), 449-459.
16.
Drug Use Forecasting Annual Report on Adult and Juvenile Arrestees. (1995). Washington, DC: National Institute of Justice.
17.
Dutton, D. B. (1978). Explaining the low use of health services by the poor: Costs, attitudes, or delivery systems?American Sociological Review, 43, 348-368.
18.
Falkin, G. P. , Pendergast, M., and Anglin, M. D. (1994). Drug treatment in the criminal justice setting. Federal Probation, 58(3), 31-36.
19.
Field, G. (1985). The cornerstone program: A client outcome study. Federal Probation, 49, 50-55.
20.
Gerstein, D. A. , & Harwood, H. J. (1990). (Eds.). Treating drug problems (Vol. 1). Washington, DC: National Academy of Sciences Press.
21.
Glaser, J. B. , & Grefinger, R. B. (1993). Correctional health care: A public health opportunity. Annals of Internal Medicine, 118, 139-145.
22.
Greenberg, S. W. , & Adler, F. (1974). Crime and addiction: An empirical analysis of the literature 1920-1973. Contemporary Drug Problems, 3, 221-270.
23.
Harwood, H. J. , Hubbard, R. L., Collins, J. J., & Rachal, J. V. (1988). The costs of crime and the benefits of drug abuse treatment. In C. G. Leukefeld & F. M. Tims (Eds.), Compulsory treatment of drug abuse: Research and clinical practice (National Institute on Drug Abuse Research Monograph No. 86, pp. 209-235). Washington, DC: U.S. Government Printing Office.
24.
Harwood, H. J. , Napolitano, D. M., Kristiansen, P., & Collins, J. J. (1984). Economic costs to society of alcohol and drug abuse an mental illness. Research Triangle, NC: Research Triangle.
25.
Holder, H. D. (1987). Alcoholism treatment and potential health care cost saving. Medical Care, 25(1), 52-71.
26.
Holder, H. D. , & Blose, J. O. (1992). The reduction of health care costs associated with alcoholism treatment: A 14-year longitudinal study. Journal of Studies on Alcohol, 53, 293-302.
27.
Hser, Y. I. , & Anglin, M. D. (1991). Cost effectiveness of drug abuse treatment: Relevant issues and alternative longitudinal modeling approaches. In W. S. Cartwright & J. M. Kaple (Eds.), Economic costs, cost-effectiveness, financing, and community-based drug treatment (NIDA research monograph, pp. 667-693). Washington, DC: U.S. Government Printing Office.
28.
Hubbard, R. L. , & French, M. T. (1991). New perspectives on the benefit-cost and cost-effectiveness of drug abuse treatment. In W. S. Cartwright & J. M. Kaple (Eds.), Economic costs, cost-effectiveness, financing, and community-based drug treatment (NIDA research monograph, pp. 94-113). Washington, DC: U.S. Government Printing Office.
29.
Hubbard, R. L. , Marsden, M. E., Rachal, J. V., Harwood, H. J., Cavanaugh, E. R., & Ginzburg, H. M. (1989). Drug abuse treatment: A national study of effectiveness. Chapel Hill: University of North Carolina Press.
30.
Inciardi, J. A. (1974). Drugs, drug-taking, and drug-seeking...notations on the dynamics of myth, change, and reality. In J. A. Inciardi & C. D. Chambers (Eds.), Drugs and the criminal justice system (pp. 203-222). Beverly Hills, CA: Sage.
31.
Inciardi, J. A. , & Chambers, C. D. (Eds.). (1974). Drugs and the criminal justice system. Beverly Hills, CA: Sage.
32.
Inciardi, J. A. , & Martin, S. S. (1993). Drug abuse treatment in criminal justice settings. The Journal of Drug Issues, 23, 1-6.
33.
Inciardi, J. A. , McBride, D. C., McCoy, H. V., & Chitwood, D. D. (1994). Recent research on the crack-cocaine/crime connection. Studies on Crime & Crime Prevention, 3, 63-82.
34.
Innes, C. A. (1988). Profile of state prison inmates. (1986). Bureau of Justice Statistics special report. Washington, DC: U.S. Department of Justice.
35.
Jones, K. R. , & Vischi, T. R. (1979). Impact of alcohol, drug abuse and mental health treatment on medical care utilization. Medical Care17(Suppl. 12).
36.
Kendig, N. , Stough, T., Austin, P., Kummer, L., Swetz, A., & Vlahov, D. (1994). Profile of HIV seropositive inmates diagnosed in Maryland's state correctional system. Public Health Reports, 109(6), 756-760.
37.
Koehler, R. J. (1994). HIV infection, TB, and the health crisis in corrections. Public Administration Review, 54(1), 31-35.
38.
Leaf, P. J. , Bruce, M. L., Tischler, G. L., Freeman, D. H., Weissman, M. M., & Myers. J. (1988). Factors affecting the utilization of specialty and general medical mental health services. Medical Care, 26, 9-14.
39.
Leukefeld, C. G. (1985). The clinical connection: Drugs and crime. The International Journal of the Addictions, 25, 621-640.
40.
Leukefeld, C. G. , Battjes, R. W., & Amsel, Z. (Eds.). (1990). AIDS and intravenous drug use: Community prevention. New York: Hemisphere.
41.
Leukefeld, C. G. , & Haverkos, H. W. (1992). Sexually transmitted diseases in adolescence. In T. P. Gullotta (Ed.), Adolescent sexuality (pp 161-190). Newbury Park, CA: Sage.
42.
Leukefeld, C. G. , & Tims, F. M. (1988). Compulsory treatment: A review of the findings. In C. G. Leukefeld & F. M. Tims (Eds.), Compulsory treatment of drug abuse: Research and clinical practice (NIDA research monograph, pp. 236-251). Washington, DC: U.S. Government Printing Office.
43.
Martinson, R. (1974). What works? Questions and answers about prison reform. Public Interest, 35, 22-45.
44.
McBride, D. C. , Chitwood, D. D., Page, J. B., McCoy, C. B., & Inciardi, J. A. (1990). AIDS, IV drug use, and the federal agenda. In J. A. Inciardi (Ed.), Handbook of drug control in the United States (pp. 267-282). Westport, CT: Greenwood.
45.
McCoy, C. B. , & Inciardi, J. A. (1995). Sex, drugs, and the continuing spread of AIDS. Los Angeles: Roxbury.
46.
Nurco, D. N. , Ball, J. C., Shaffer, J. W., & Hanlon, T. F. (1985). The criminality of narcotic addicts. Journal of Nervous and Mental Disease, 173, 94-102.
47.
Office of the National Drug Control Policy . (1995). National drug control strategy. Washington, DC: U.S. Government Printing Office.
48.
Padgett, D. K. , & Brodsky, B. (1992). Psychosocial factors influencing non-urgent use of the room: A review of the literature and recommendations for research and emergency improved service delivery. Social Science and Medicine, 35, 1189-1197.
49.
Padgett, D. , Struening, E. L., & Andrews, H. (1990). Factors affecting the use of medical, mental health, alcohol, and drug treatment by homeless adults. Medical Care, 28, 805-821.
50.
Pickens, R. W. , Leukefeld, C. G., & Schuster, C. R. (Eds.). (1991). Improving drug abuse treatment (NIDA Monograph No. 106). Washington, DC: U.S. Government Printing Office.
51.
Platt, J. J. (1995). Heroin addiction: Theory, research and treatment (Vol. 2). Malabar, FL: Krieger.
52.
Rice, D. P. , Kelman, S., Miller, L. S., & Dunmeyer, S. (1990). The economic costs of alcohol and drug abuse and mental illness: 1985. San Francisco: Institute for Health and Aging.
53.
Rosenstock, I. M. (1966). Why people use health services. Milbank Memorial Fund Quarterly, 44, 94-124.
54.
Selwyn, P. A. , Budner, N. S., Wasserman, W. C., & Arno, P. S. (1994). Utilization of on-site primary care services by HIV-seropositive and seronegative drug users in a methadone maintenance program. Public Health Reports, 108(4), 492-500.
55.
Simpson, D. D. , & Sells, S. B. (1990). (Eds.). Opioid addiction and treatment: A 12-year follow-up. Malabar, FL: Krieger.
56.
Thaul, S. , Lohr, K. N, & Tranquanda, R. E. (Eds.). (1994). Health services research: Opportunities for an expanding field of inquiry. Washington, DC: National Academy Press.
57.
Vlahov, D. T. , Brewer, F., Castro, K. G., Narkunas, J. P., Salive, M. E., Ullrich, J., & Munoz, A. (1991). Prevalence of antibody to HIV-1 among entrants to US correctional facilities. Journal of the American Medical Association, 265, 1129-1132.
58.
Wexler, H. K. , Falkin, G. P., Lipton, D. S., & Rosenblum, A. B. (1992). Outcome evaluation of a prison therapeutic community for substance abuse treatment. In C. G. Leukefeld & F. M. Tims (Eds.), Drug abuse treatment in prisons and jails (NIDA Monograph No. 118, pp. 156-175). Washington, DC: U.S. Government Printing Office.
59.
Wexler, H. K. , & Graham, W. (1994, August). Prison-based therapeutic communities for substance abusers. Paper presented at the American Psychological Association Convention, Los Angeles.
